The 6-hydroxydopamine Rat Model of Parkinson's Disease

被引:18
|
作者
Guimaraes, Rayanne Poletti [1 ]
Ribeiro, Danilo Leandro [1 ]
dos Santos, Keila Bariotto [1 ]
Godoy, Livea Dornela [1 ]
Correa, Mirella Rosine [1 ]
Padovan-Neto, Fernando Eduardo [1 ]
机构
[1] Univ Sao Paulo, Fac Philosophy Sci & Letters Ribeirao Preto, Dept Psychol, Sao Paulo, Brazil
来源
基金
巴西圣保罗研究基金会;
关键词
DOPA-INDUCED DYSKINESIA; MEDIAL FOREBRAIN-BUNDLE; ANIMAL-MODELS; SUBSTANTIA-NIGRA; PARTIAL LESION; BASAL GANGLIA; 6-OHDA; MOTOR; RECOVERY; DEFICITS;
D O I
10.3791/62923
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Motor symptoms of Parkinson's disease (PD)-bradykinesia, akinesia, and tremor at rest-are consequences of the neurodegeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc) and dopaminergic striatal deficit. Animal models have been widely used to simulate human pathology in the laboratory. Rodents are the most used animal models for PD due to their ease of handling and maintenance. Moreover, the anatomy and molecular, cellular, and pharmacological mechanisms of PD are similar in rodents and humans. The infusion of the neurotoxin, 6hydroxydopamine (6-OHDA), into a medial forebrain bundle (MFB) of rats reproduces the severe destruction of dopaminergic neurons and simulates PD symptoms. This protocol demonstrates how to perform the unilateral microinjection of 6-OHDA in the MFB in a rat model of PD and shows the motor deficits induced by 6-OHDA and predicted dopaminergic lesions through the stepping test. The 6-OHDA causes significant impairment in the number of steps performed with the contralateral forelimb.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] The study of neuroprotective drugs in the striatal and the MFB 6-hydroxydopamine rat model for Parkinson's disease
    Mertens, B.
    Massie, A.
    Michotte, Y.
    Sarre, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 73 - 73
  • [32] Synchrotron FTIR Microspectroscopy Study of the Striatum in 6-Hydroxydopamine Rat Model of Parkinson's Disease
    Zhu Hongyan
    Xiao, Pei
    Wu Lingyan
    Bo, Liu
    Qi Zeming
    Wang Yuyin
    SPECTROSCOPY-AN INTERNATIONAL JOURNAL, 2012, 27 (04): : 229 - 238
  • [33] Neuroprotective and Antiapoptotic Potential of Trigonelline in a Striatal 6-Hydroxydopamine Rat Model of Parkinson's Disease
    Mirzaie, M.
    Khalili, M.
    Kiasalari, Z.
    Roghani, M.
    NEUROPHYSIOLOGY, 2016, 48 (03) : 176 - 183
  • [34] Behavioral and Histological Effects of Lipopolysaccharide Preconditioning in a 6-Hydroxydopamine Rat Model of Parkinson's Disease
    Golpich, M.
    Amini, E.
    Mohamed, Z.
    Raymond, A. A.
    Norlinah, M. I.
    Ahmadiani, A.
    PUBLIC HEALTH GENOMICS, 2015, 18 : 37 - 37
  • [35] Neuroprotection by safinamide in the 6-hydroxydopamine (6-OHDA) model of Parkinson's disease
    Sadeghian, M.
    Roach, A.
    Smith, K. J.
    MOVEMENT DISORDERS, 2011, 26 : S286 - S286
  • [36] Characterisation of a novel rat model of Parkinson's disease, combining intrastriatal 6-hydroxydopamine and intranigral lipopolysaccharide
    Kelly, Mark
    Yssel, Justin D.
    Connor, Thomas
    Nolan, Yvonne
    Harkin, Andrew
    IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 : S82 - S82
  • [37] Effect of Chronic Administration of Ferulic Acid in 6-Hydroxydopamine Lesioned Rat's Model of Parkinson's Disease
    Khawade, Ajinkya
    More, Ganesh
    Aswar, Urmila
    Aswar, Manoj
    INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S247 - S247
  • [38] Cognitive-Enhancing Effect of Quercetin in a Rat Model of Parkinson's Disease Induced by 6-Hydroxydopamine
    Sriraksa, Napatr
    Wattanathorn, Jintanaporn
    Muchimapura, Supaporn
    Tiamkao, Somsak
    Brown, Kamoltip
    Chaisiwamongkol, Kowit
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012 : 1 - 9
  • [39] Nicotine ameliorates behavioural deficits and oxidative stress in a 6-hydroxydopamine rat model of Parkinson's disease
    Ciobica, A.
    Hritcu, L.
    Artenie, V.
    Padurariu, M.
    Olteanu, Z.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S288 - S288
  • [40] Unchanged striatal expression of Ceramide transfer protein in a 6-hydroxydopamine Parkinson's disease rat model
    Mencarelli, C.
    Bode, G. H.
    Losen, M.
    Vlamings, R.
    Temel, Y.
    De Baets, M. H.
    Steinbusch, H. W.
    Martinez-Martinez, P.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 48 - 49